Tcr2 Therapeutics Inc.

VICTORY CAPITAL MANAGEMENT INC

Report date

12/31/2022

Quarter

2022 Q4

Filed

4/25/2023

Shares

74,297

Value ($000)

74

Weight

0.0%

2019 Q4 - 2022 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q4	4/25/2023	74	0.0%	74,297	12/31/2022
2022 Q3	11/2/2022	152	0.0%	84,242	9/30/2022
2022 Q2	8/1/2022	249	0.0%	85,827	6/30/2022
2022 Q1	5/4/2022	181	0.0%	84,792	3/31/2022
2021 Q4	2/7/2022	393	0.0%	84,407	12/31/2021
2021 Q3	11/2/2021	829	0.0%	97,413	9/30/2021
2021 Q2	8/3/2021	2,294	0.0%	139,740	6/30/2021
2021 Q1	5/4/2021	27,189	0.0%	1,231,400	3/31/2021
2020 Q4	2/1/2021	6,465	0.0%	209,016	12/31/2020
2020 Q3	11/9/2020	2,799	0.0%	137,765	9/30/2020
2020 Q2	8/7/2020	1,283	0.0%	83,499	6/30/2020
2020 Q1	5/4/2020	652	0.0%	84,241	3/31/2020
2019 Q4	2/6/2020	1,234	0.0%	86,432	12/31/2019